Clinomic Revenue and Competitors
Estimated Revenue & Valuation
- Clinomic's estimated annual revenue is currently $18.3M per year.
- Clinomic's estimated revenue per employee is $251,000
Employee Data
- Clinomic has 73 Employees.
- Clinomic grew their employee count by 11% last year.
Clinomic Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $19.6M | 78 | 11% | N/A | N/A |
#2 | $142.3M | 567 | -3% | N/A | N/A |
#3 | $8.5M | 34 | 0% | N/A | N/A |
#4 | $58.7M | 234 | 38% | N/A | N/A |
#5 | $15.1M | 60 | 11% | N/A | N/A |
#6 | $73.5M | 293 | 28% | N/A | N/A |
#7 | $28.4M | 113 | 14% | N/A | N/A |
#8 | $22.3M | 89 | 35% | N/A | N/A |
#9 | $96.4M | 384 | N/A | N/A | N/A |
#10 | $24.1M | 96 | 4% | N/A | N/A |
What Is Clinomic?
Clinomic is a dynamic, fast-growing start-up focussed on developing innovative technological solutions for critically ill patients. We create groundbreaking solutions for the critically ill by combining translational medical research, data science and computational intelligence. With a patient-centric view, we combine state-of-the-art research with modern technologies to enable an optimal treatment for every patient. Legal : https://www.clinomic.ai/imprint/ Privacy: https://www.clinomic.ai/data-privacy/
keywords:N/A
N/A
Total Funding
73
Number of Employees
$18.3M
Revenue (est)
11%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Clinomic's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Quality Assurance Lead | Reveal Email/Phone |
Clinomic News
Evolucare, Clinomic, Ascom, PICIS, GE Healthcare, Mela Solutions, NEXUS AG, Philips NV, Bow Medical, iMDsoft.
Clinomic Gmbh · Czech Academy of Sciences · Emovo Care Sa · Iit-G · Imito Ag · Kth Royal Institute of Technology · Medkitdoc.
Other Companies in Aachen
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $19.8M | 90 | 36% | N/A |
#2 | N/A | 90 | 50% | N/A |
#3 | $17.4M | 120 | 8% | N/A |
#4 | $35.6M | 147 | 9% | N/A |
#5 | $53.4M | 147 | -13% | N/A |